Form 4 for EW Edwards Lifesciences
Accepted 2024-09-03 00:00:00 ET · period of report 2024-09-03 · accession 0001225208-24-008339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-03 | 2024-09-03 | EW | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +10.9K | 86.8K | +14% | $0 | |
| 2024-09-03 | 2024-09-03 | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $69.96 | -5,530 | 81.3K | -6% | -$386.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-03 | A | A | 10,910 | $0.00 | 86,817.44 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-03 | F | D | 5,530 | $69.96 | 81,287.44 | D | — | — |